6505--Domestic Pharmaceuticals/Med/Surge

DEPARTMENT OF VETERANS AFFAIRS

Veterans Health Administration

Consolidated Mail Outpatient Pharmacy (CMOP)

3450 S. 4th Street

Leavenworth, KS 66048

Page 8 of 8

The Department of Veterans Affairs is seeking interested sources for the requirement entitled:

CONSOLIDATED MAIL OUTPATIENT PHARMACY (CMOP) DOMESTIC PHARMACEUTICALS

This is a Sources Sought announcement only this is not a Request for Proposal. The purpose of this notice is to conduct market research and obtain information from qualified contractors with special interest. No solicitation is being issued at this time. This notice shall not be construed as a commitment by the Government to ultimately award a contract, nor does it restrict the Government to a particular acquisition approach.

The Government has established an ongoing requirement for the provision of domestically manufactured pharmaceuticals. In accordance with Federal Acquisition Regulation (FAR) part 15.201(c), the Agency is encouraged to promote early exchanges of information about future acquisitions. An early exchange of information in the acquisition process can identify and resolve concerns regarding the acquisition strategy, including proposed contract type, terms and conditions, and acquisition planning schedules; the feasibility of the requirement, including performance requirements, statements of work, and data requirements; the suitability of the proposal instructions and evaluation criteria, including the approach for assessing past performance information; the availability of reference documents; and any other industry concerns or questions.

The Consolidated Mail Outpatient Pharmacy program (CMOP) is seeking potential small and large business domestic pharmaceutical manufacturer sources capable of providing the following pharmaceuticals:

Glucose test strips & lancets 33G used to test blood sugar

(Brand Name: One Touch, Accu-Chek & Trueplus; common box count: 50CT, 100CT)

HCTZ 12.5/Irbesartan treatment of hypertension

(common strengths: 300MG; common bottle counts: 90CT)

HCTZ 12.5MG/Losartan treatment of hypertension (common strengths: 50MG; common bottle count: 90CT)

HCTZ 25MG/Valsartan 320MG TAB treatment of hypertension (common bottle count: 90CT)

Clomiphene Citrate used to induce ovulation (egg production)

(common strength: 50MG; common bottle count: 30CT)

Acamprosate CA EC TAB used to help overcome alcoholism

(common strength: 333MG; common bottle count: 180CT)

Clindamycin 1% topical solution used to treat acne lesions

(common strength: 1.4%; common bottle count: 60CT)

Lansoprazole treatment of ulcers

(common strength: 15MG & 30MG Disintegrate; common bottle count: 100CT)

Abaloparatide used for those who suffer from high risk osteoporosis

(common strength: 80MCG; common bottle count: 30CT)

Minimed infusion sets (brand name) used to administer insulin injections (common box count: 10CT)

Tandem Autosoft 90 insulin infusion set (brand name) used to administer insulin injections

(common box count: 10CT)

EE 0.03mg/Levonorg 0.15mg tab birth control for women

Esomeprazole 20MG (Base) EC CAP used for the treatment of erosive esophagitis (common bottle count: 90CT)

Esomeprazole Magnesium 40MG EC CAP - used for the treatment of erosive esophagitis (common bottle count: 90CT)

Fosinopril NA 40MG Tab used for the treatment of hypertension (common bottle count: 90CT)

Fesoterodine Fumarate SA Tab used for the treatment of overactive bladder (common strength: 4MG & 8MG; common bottle count: 30CT)

Glipizide - used to improve glycemic control in adults with diabetes (common strength: 2.5MG & 10MG; common bottle count: 30CT & 500CT)

Galantamine Hydrobromide SA Cap - Treatment of mild to moderate dementia of the Alzheimer's type (common strength: 8MG & 16MG; common bottle count: 30CT)

Gabapentin (Eqv-Gralise) 600MG TAB - Indicated for the management of postherpetic neuralgia (common bottle count: 90CT)

Sumatriptan 6MG/0.5ML INJ Syringe 0.5ML used for treatment of migraines (common bottle count: 2CT)

Fenofibrate used to reduce elevated low-density lipoprotein cholesterol (LDL-C), total cholesterol (Total-C), Triglycerides and apolipoprotein B (Apo B), and to increase high-density lipoprotein cholesterol (HDL-C) in adult patients with primary hypercholesterolemia or mixed dyslipidemia (common strength: 145MG & 48MG; common bottle count: 30CT & 90CT)

Phenytoin NA 100MG SA Cap - used in the management and treatment of epilepsy (common bottle count: 1000CT)

Sevelamer Carbonate 800MG Tab - indicated for the control of serum phosphorus in adults with chronic kidney disease on dialysis (common bottle count: 270CT)

Brinzolamide 1% OPH SUSP PS 10ml treatment of intraocular pressure

Cath Set, Intermit 14FR catheter system (brand name) (part numbers: H#96144, H#B14FB, & H#71164)

Reservoir, T:SLIM X2 W/T:LOCK,3ML (brand name: Tandem) insulin delivery reservoir

Capecitabine 150MG TAB used for treatment of patients with cancer (common bottle count: 60CT)

Desoximetasone 0.05% Cream - for the relief of inflammatory manifestations of corticosteroid responsive dermatoses (common bottle count: 60GM)

Dicloxacillin NA 500MG CAP - to reduce the development of drug resistant bacteria (common bottle count: 100CT)

Dipyridamole 50MG TAB - adjunct to coumarin anticoagulants in the prevention of postoperative thromboembolic complications (common bottle count: 100CT)

Darifenacin 15MG SA TAB - treatment of overactive bladder symptoms of urge urinary incontinence (common bottle count: 30CT)

Drospirenone 4MG TAB- birth control (common bottle count: 28CT)

Entacapone 200MG TAB - adjunct to levodopa and carbidopa to treat end of dose wearing off in patients with Parkinson's disease (common bottle count: 100CT)

Epinastine HCL 0.05% OPH SOLN 5ML - prevention of itching associated with allergic conjunctivitis (common bottle count: 5ML

Zolmitriptan 5MG/Spray Nasal Soln 0.1ML -used for the acute treatment of migraines (common bottle count: 6)

Amlodipine 5/Benazepril used for treatment of hypertension (common strengths: 10MG, 20MG, 40MG; common bottle count: 500CT & 1000CT)

Amlodipine 10MG/ Benazepril used for treatment of hypertension (common strength: 20MG; common bottle count: 500CT)

Mesalamine used for the maintenance of remission of ulcerative colitis in adults (common strength: 375MG & 800MG; common bottle count: 120CT & 180CT)

Adapalene 0.1% Top Gel 45GM used for treating acne vulgaris

Brimonidine Tartrate 0.025% OPH SOLN 2.5ML relives redness in eyes (common bottle count: 1)

Carboxymethylcellulose NA 0.25% OPH SOLN 15ML relieves dry eyes (common bottle count: 15)

Abacavir SO4 600MG/Lamivudine 300MG TAB treatment of HIV (common bottle count: 30CT)

Erythromycin 0.5% OPH OINT 3.5GM treatment of ocular injections (common bottle count: 1)

Fluoxetine HCL 90MG EC CAP 4CT treatment of major depressive disorder (common bottle count: 4CT)

Microgestin 1.5/30 TAB prevention of pregnancy in women (common bottle count: 6CT)

Metformin HCL 500MG management of type 2 diabetes (common bottle count: 30CT)

Tamsulosin HCL 0.4MG - treatment of the signs and symptoms of benign prostatic hyperplasia (common bottle count: 100CT)

Armour Thyroid used to treat underactive thyroid (common strength: 180MG, 120MG, 90MG, 60-65MG, 30-32.5MG; common bottle count: 100 CT)

Abaloparatide 80MCG/0.04ML, 1.56ML Pen - for the treatment of postmenopausal women with osteoporosis and men with osteoporosis who are a high risk for fracture or who have failed or are intolerant to other available osteoporosis therapy

Potential contractor(s) will manufacture the aforementioned pharmaceuticals domestically for an estimated seven facilities and will be responsible for providing all labor, materials, quality assurance, delivery and supervision in compliance with federal, state and local regulations. The North American Industry Classification System (NAICS) code associated with this request for information is: 325412 & 325413, which has a business size standard of 1,250 employees. Interested manufacturers are reminded that in accordance with FAR 4.12, prospective contractors shall complete electronic annual representations and certifications in conjunction with FAR 4.11 required registration in the System for Award Management (SAM) database prior to award of a contract.

If you believe you are capable of meeting the requirement, please provide a complete capability statement and response by no later than FEBRUARY 5, 2025, at 16:30 CDT to Josie Linaweaver at josie.linaweaver@va.gov. A complete response satisfies the information requested below.

The Government requests responders provide the following information:

Company information including name, address, point of contact, identification of any socioeconomic categories (i.e. SDVOSB, VOSB, 8a, etc) the company falls under, business size and DUNS Number

The pharmaceutical(s) which are being manufactured domestically

Authorized distributors who distribute the domestically manufactured pharmaceutical(s)

Average cost of common prescription quantities

In the last twelve (12) months how many times has the stock not been available for shipment and how quickly are pharmaceuticals restocked

The contract number of any applicable GSA/FSS/NAC schedule if one exists from which these items can be procured under

Further, if you believe a different NAICS code or Product Service Code (PSC) is a better fit for the subject requirement, please provide that information to us as well

PLEASE NOTE: This RFI is issued solely for information and planning purposes only and does not constitute a solicitation. All information received in response to this RFI that is marked as proprietary will be handled accordingly. In accordance with FAR 15.201(e), responses to this notice are not offers and cannot be accepted by the Government to form a binding contract. Responders are solely responsible for all expenses associated with responding to this RFI.